메뉴 건너뛰기




Volumn 2, Issue 4, 2001, Pages 341-349

Zevalin™: 90Ytrium labeled anti-CD20 (Ibritumomab tiuxe tan), a new treatment for non-Hodgkin's lymphoma

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; CHELATING AGENT; IBRITUMOMAB TIUXETAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; INDIUM; MONOCLONAL ANTIBODY; PENTETIC ACID DERIVATIVE; RITUXIMAB; UNCLASSIFIED DRUG; YTTRIUM; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT;

EID: 0034747392     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389201013378545     Document Type: Article
Times cited : (50)

References (59)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.